Tradestie Institutional Equity Comparison Engine

MLTX vs VERA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MLTX Overall Edge

MLTX Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) driven by superior Growth & Margin, Options & Structure while VERA counters with relative strength in Momentum & Technical. Fundamentally, MLTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VERA at N/M Forward P/E and -4160.1% operating margin (+0.0% YoY). In options structure, MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against VERA sits in BREAKDOWN (68th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MLTX N/M vs VERA N/M Fwd P/E
Growth & Margin Winner MLTX
Op Margin 0.0% vs -4160.1% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner VERA
1Y -5.7% vs -3.9% ยท 52W Pos 17% vs 3%
Options & Structure Winner MLTX
BREAKDOWN (7th %ile IV) vs BREAKDOWN (68th %ile IV)
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0
VERA NASDAQ
Vera Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$27.26
-2.99% 1D
Market Cap $2.1B
1M Return -2.22%
1Y Return -3.91%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 32.0 Fund 51.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MLTX -5.65% VERA -3.91% Spread: +1.74 pp (VERA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MLTX TTM Op. Margin: 0.0% VERA TTM Op. Margin: -4160.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLTX vs VERA. Trailing 12-month operating profitability (MLTX 0.0% vs VERA -4160.1%) and valuation multiples (MLTX N/M vs VERA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MLTX (3) vs VERA (3)
Institutional Metric MLTX VERA Criterion Row Winner
Market Capitalization Scale $1.1B $2.1B Larger Scale VERA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% -4160.1% Higher Margin MLTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -81.5% -113.5% Higher ROE MLTX
52-Week Range Position Momentum 17% ($9โ€“$23) 3% ($26โ€“$56) Stronger Trend MLTX
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 90% Vol 1.12ฮฒ ยท 57% Vol Lower Realized Risk VERA
Unified Institutional Score Composite Signal 38.3 / 100 (SELL) 45.9 / 100 (HOLD) Higher Composite VERA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MLTX vs VERA Buy Guide
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VERA BREAKDOWN
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 68th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VERA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MLTX nor VERA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.